Occlusive treatment in psoriasis: how does it work?
Lotti
T
T
D000287:Administration, Topical; D015415:Biomarkers / Q000032:analysis; D004817:Epidermis / Q000276:immunology; D006801:Humans; D009779:Occlusive Dressings; D010960:Plasminogen Activators / Q000032:analysis; D011565:Psoriasis / Q000276:immunology / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000032:analysis; D014568:Urokinase-Type Plasminogen Activator / Q000032:analysis
D015415:Biomarkers; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator